Homebiotech

biotech

biotech

Cyclerion and Korsana announce merger

Jim Cornall - April 9, 2026

biotech

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

Jim Cornall - April 9, 2026

biotech

Positive results from moderate-to-severe atopic dermatitis trial

Jim Cornall - April 8, 2026

biotech

Centessa Pharmaceuticals to be acquired by Lilly

Jim Cornall - April 8, 2026

biotech

‘Groundbreaking’ rapid diagnostic test for prostate cancer

Jim Cornall - November 25, 2025

biotech

Breakthrough in cancer immunotherapy using marine bacteria

Jim Cornall - November 24, 2025

biotech

Trial results could shorten TB treatment time

Jim Cornall - November 24, 2025

biotech

Customised cells to fight brain cancer

Jim Cornall - November 24, 2025

AI

Base to Base biotech podcast 36: Gothenburg, Charcot-Marie-Tooth disease and Ultrasound AI

Jim Cornall - November 21, 2025

biotech

New technique could speed up design of drugs that target proteins

Jim Cornall - November 20, 2025

biotech

Fast track designation for diagnostic agent for clear cell renal cell carcinoma

Jim Cornall - November 20, 2025

biotech

Sofinnova Partners closes $750m fund

Jim Cornall - November 20, 2025

1...282930...68 Page 29 of 68

Stay Connected

- Advertisement -

spot_img

Latest Articles

biotech

Cyclerion and Korsana announce merger

Jim Cornall - April 9, 2026 0

Cyclerion Therapeutics, Inc. and Korsana Biosciences, Inc. have entered into a definitive merger agreement for an all-stock transaction. Upon completion of the transaction, the...

“Groundbreaking” data for Charcot-Marie-Tooth disease type 1A treatment

biotech Jim Cornall - April 9, 2026 0

Positive results from moderate-to-severe atopic dermatitis trial

biotech Jim Cornall - April 8, 2026 0

Centessa Pharmaceuticals to be acquired by Lilly

biotech Jim Cornall - April 8, 2026 0

Smart drugs to fight cancer

biotech Jim Cornall - April 8, 2026 0